dantheclamman@lemmy.world to News@lemmy.world · 10 months agoBig Pharma spends billions more on executives and stockholders than on R&Darstechnica.comexternal-linkmessage-square38fedilinkarrow-up1525arrow-down13cross-posted to: health@lemmy.worldnews@lemmy.worldpublichealth@mander.xyztechnology@lemmy.world
arrow-up1522arrow-down1external-linkBig Pharma spends billions more on executives and stockholders than on R&Darstechnica.comdantheclamman@lemmy.world to News@lemmy.world · 10 months agomessage-square38fedilinkcross-posted to: health@lemmy.worldnews@lemmy.worldpublichealth@mander.xyztechnology@lemmy.world
minus-squarecomador @lemmy.worldlinkfedilinkarrow-up10·edit-210 months agoIn San Diego, big pharma is now heavily investing into AI to do a lot of the chemical compound matching that was traditionally done by people like chemists and biotech employees too. More money for the company, less paychecks to dispense. edit links: https://www.technologyreview.com/2023/02/15/1067904/ai-automation-drug-development/ https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality
In San Diego, big pharma is now heavily investing into AI to do a lot of the chemical compound matching that was traditionally done by people like chemists and biotech employees too.
More money for the company, less paychecks to dispense.
edit links:
https://www.technologyreview.com/2023/02/15/1067904/ai-automation-drug-development/
https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality